Share on StockTwits

Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 40,000 shares of the stock on the open market in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $41.65, for a total transaction of $1,666,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Dolby Laboratories (NYSE:DLB) traded up 0.97% on Thursday, hitting $41.49. The stock had a trading volume of 407,376 shares. Dolby Laboratories has a 52 week low of $30.88 and a 52 week high of $42.14. The stock has a 50-day moving average of $40.81 and a 200-day moving average of $36.24. The company has a market cap of $4.238 billion and a price-to-earnings ratio of 23.21.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Thursday, January 23rd. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.25. The company had revenue of $231.30 million for the quarter, compared to the consensus estimate of $212.08 million. During the same quarter in the previous year, the company posted $0.64 earnings per share. The company’s revenue for the quarter was down 2.2% on a year-over-year basis. Analysts expect that Dolby Laboratories will post $1.65 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at TheStreet upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Analysts at Zacks upgraded shares of Dolby Laboratories from an “underperform” rating to a “neutral” rating in a research note on Tuesday, December 31st. They now have a $39.40 price target on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. Dolby Laboratories has a consensus rating of “Hold” and a consensus target price of $35.47.

Dolby Laboratories, Inc develops and delivers products and technologies that are used in the entertainment industry.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.